| Name | Title | Contact Details |
|---|
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
Uniting the World through Health and Happiness.
AIT Laboratories is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
For more than 130 years, Carstens has focused on the specific and evolving needs of healthcare professionals - providing revolutionary solutions that transform clinical environments, enhance patient experiences and positively impact results. The first to bring patient information to the point of care, we have always been passionate about connecting with the human side of healthcare. Today, we continue to lead the industry with our inventive product development - bringing new solutions to new demands for more efficient, productive and interactive care. Carstens - connecting with the human side of healthcare.
Camino Medical Group is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.